Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,320.00    0.00 (0.00%)
Bid:
2,315.00
Ask:
2,320.00
Spread: 5.00 (0.216%)
Market Cap: £3.15b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

17 Nov 2023 07:00

RNS Number : 7559T
RIT Capital Partners PLC
17 November 2023
Β 

RIT Capital Partners PLC (LEI: P31Q1NLTW35JJGHA4667)

Β 

17 November 2023

Β 

31 October 2023 Net Asset Value

Β 

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 31 October 2023 (with debt at fair value) was 2,362p per Β£1 ordinary share (30 September 2023: 2,409p). This is after deduction of the second interim dividend of 19p per Β£1 ordinary share paid on 27 October 2023.

Β 

Β 

October 2023 Highlights

Β 

Global equities retreated in October as higher bond yields and renewed geopolitical concerns put pressure on equity valuations. In the US, buoyant economic data reinforced a higher-for-longer rate environment which pushed the 10-year Treasury yield above 5% for the first time since 2007. The S&P 500 declined by -2.1% over the month, while weakening economic growth in the UK and Europe led to declines of -3.7% for the FTSE 100 and -3.6% for the STOXX 600. Investor sentiment towards China weakened, with the CSI 300 down -3.1%. Gold rallied by ~7.3% as investors sought safe haven assets, while the US dollar strengthened slightly in the month.

Β 

Our portfolio declined less than the markets driven by our moderate net equity exposure, positive contributions from our Uncorrelated Strategies as well as our meaningful US dollar position.

Β 

Β·

Our Quoted Equities book detracted during the month. Positive contributions from Japanese holdings were offset by weakness in certain value positions, alongside declines in our healthcare and Chinese holdings.

Β·

Private Investments were approximately flat for the month, with no major movements from the new marks received from our private funds for Q3. As of 31 October, 12% of private funds were valued at 30 September reported valuations and 83% were held at 30 June valuations, with the remainder held at 31 March. All private direct positions are valued at 30 June.

Β·

Our Uncorrelated Strategies book was steady in October. Our macro strategies and gold position contributed positively during the month, while credit strategies detracted.

Β·

The Board continued its active buyback programme, generating a further accretive impact to the NAV per share. In the month of October, the Company repurchased approximately 0.7 million shares on behalf of shareholders.

Β 

Β 

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

Β 

Numis (Joint Broker):

David Benda

T: 020 7260 1000

Β 

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

Β 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Tom Burns

T:Β 020 7404 5959

E:Β RIT@BrunswickGroup.comΒ 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NAVVQLFFXFLEFBL
Date   Source Headline
12th Aug 20227:00 amRNSNet Asset Value(s)
11th Aug 20229:45 amRNSBoard Appointments
2nd Aug 20227:00 amRNSHalf-year Report
20th Jul 20227:00 amRNSNet Asset Value(s)
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 20227:00 amRNSTransaction in Own Shares
16th Jun 20227:00 amRNSNet Asset Value(s)
17th May 20227:00 amRNSNet Asset Value(s)
4th May 20224:51 pmRNSResult of AGM
27th Apr 20222:24 pmRNSDirector/PDMR Shareholding
26th Apr 20224:40 pmRNSBoard Appointment
19th Apr 20227:00 amRNSNet Asset Value(s)
14th Mar 20227:00 amRNSNet Asset Value(s)
1st Mar 20227:00 amRNSAnnual Financial Report
23rd Feb 20224:18 pmRNSHolding(s) in Company
22nd Feb 20222:45 pmRNSHolding(s) in Company
17th Feb 20227:00 amRNSNet Asset Value(s)
15th Feb 20224:26 pmRNSHolding(s) in Company
28th Jan 20227:00 amRNSNet Asset Value(s)
15th Dec 20217:00 amRNSNet Asset Value(s)
3rd Dec 20217:00 amRNSDirector Declaration
23rd Nov 20215:22 pmRNSDirector/PDMR Shareholding
15th Nov 20217:00 amRNSNet Asset Value(s)
4th Nov 20214:57 pmRNSBoard Announcements
15th Oct 20217:00 amRNSNet Asset Value(s)
15th Sep 20217:00 amRNSNet Asset Value(s)
16th Aug 20217:00 amRNSNet Asset Value(s)
2nd Aug 20217:00 amRNSHalf-year Report
20th Jul 20217:00 amRNSNet Asset Value(s)
28th Jun 20216:17 pmRNSDirector/PDMR Shareholding
28th Jun 20217:00 amRNSTransaction in Own Shares
22nd Jun 20217:00 amRNSTransaction in Own Shares
15th Jun 20217:00 amRNSNet Asset Value(s)
21st May 20215:15 pmRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSNet Asset Value(s)
22nd Apr 20215:52 pmRNSResult of AGM
19th Apr 20217:00 amRNSNet Asset Value(s)
13th Apr 20214:17 pmRNSHolding(s) in Company
1st Apr 20217:00 amRNSDirector/PDMR Shareholding
24th Mar 20216:17 pmRNSDirector/PDMR Shareholding
16th Mar 20217:00 amRNSTransaction in Own Shares
12th Mar 20217:00 amRNSNet Asset Value(s)
11th Mar 20217:00 amRNSHolding(s) in Company
5th Mar 20219:38 amRNSDirector/PDMR Shareholding
2nd Mar 20217:00 amRNSAnnual Financial Report
26th Feb 20218:10 amRNSHolding(s) in Company
17th Feb 20217:00 amRNSHolding(s) in Company
15th Feb 20217:00 amRNSNet Asset Value(s)
4th Feb 20217:00 amRNSNet Asset Value(s)
23rd Dec 20207:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.